Incretin ReviewResearch · Context · Care

Volume 01 / Evidence & interpretation / October 2026

Read past
the headline.

Behind every treatment number is a question about who was studied, what was measured and what the result can actually support.

Read the evidence note
The evidence desk

Precise numbers deserve
equally precise context.

Our reading method →
Read the evidence more carefully

The evidence notes.

01Evidence note 01

A 20% lower hazard is not a 20-point difference

Reading the SELECT cardiovascular trial without confusing a relative measure, an observed proportion and a personal forecast.

Read the note ↗
02Evidence note 02

Why a safety-report count is not an event rate

Reports can reveal important signals without providing a denominator, a causal verdict or a fair ranking of medicines.

Read the note ↗
03Evidence note 03

When a study result becomes a marketing claim

Follow the chain from the original research to the product, population and service being advertised.

Read the note ↗
04Evidence methods

A composite endpoint contains more than one outcome

Before repeating a cardiovascular claim, identify what counted as an event and how the result was measured.

Read the note ↗
05Research appraisal

Read the funding statement, then keep reading the methods

Sponsorship is relevant context. It does not replace examination of the study question, design and reporting.

Read the note ↗
06Reading boundaries

What you can responsibly take from a trial abstract

An abstract can orient a reader while leaving important methods and results outside the available view.

Read the note ↗
07Scientific article

ESSENCE and MASH: Reading the Biopsy Evidence Before Long-Term Outcomes

The 72-week ESSENCE analysis found meaningful biopsy improvements with weekly injectable semaglutide. Its accelerated MASH approval rests on those findings, while longer follow-up addresses liver complications and survival.

Read the note ↗
08Scientific article

Oral Orforglipron in ATTAIN-1: Weight Results, Safety, and Formulation

The 72-week trial established a weight-loss benefit over placebo. Interpreting that benefit requires separating study doses from marketed tablets, averages from individual responses, and clinical evidence from care-plan claims.

Read the note ↗
Public offers, examined

The care dossiers.

Promotional #1

CoreAge Rx

Compounded-treatment offer

Which statements describe the offer, and which require evidence about the actual preparation?

Open dossier ↗
Promotional #2

SuperHealthy Rx

Promotional compounded-treatment bundle

Does the dated promotion match the complete offer presented at checkout?

Open dossier ↗
Promotional #3

Likeness Rx

Compounded GLP-1 term plans

Is the comparison using a monthly charge, a term total or a monthly equivalent?

Open dossier ↗
Additional option

Ro

Membership with medication billed separately

Which evidence belongs to the medication, and which describes the membership service?

Open dossier ↗
Additional option

WeightWatchers

Med+ clinical membership

Does a cited result evaluate this exact program, or only a component of treatment?

Open dossier ↗
Additional option

LillyDirect

Manufacturer access pathway

Which organization supplies the care, which supplies the medicine and which sets each charge?

Open dossier ↗
Additional option

Hers

Care membership; medication purchased separately

Which claims on the Hers offer are medicine evidence and which concern the service itself?

Open dossier ↗
Additional option

Henry Meds

Bundled compounded medication programs

Does the research cited for an ingredient match Henry’s proposed formulation?

Open dossier ↗
Additional option

Calibrate

Clinical support and individual coaching

What population and analysis support Calibrate’s program-results claims?

Open dossier ↗
Additional option

Sesame

Success by Sesame care subscription

Are Sesame’s displayed weight-loss milestones platform outcomes or summaries of drug research?

Open dossier ↗
Additional option

OurView Health

Monthly or three-month prepaid compounded GLP-1 plans

When does my next charge process, what happens to an unused prepaid balance, and who handles my clinical follow-up?

Open dossier ↗
Additional option

Queen RX

Three-month compounded GLP-1 packages advertised as one-time purchases

Which state list, consultation format, pharmacy and refund agreement apply to my current one-time package?

Open dossier ↗
Compare all twelve options ↗